C-Quadrat Accumulate (old: Hold) Target: Euro (old: Euro 27)

Similar documents
S IMMO. Target: Euro 6.50 (unchanged) 23 November Price (Euro) weeks range 5.03 / André Hüsemann, CREA Stefan Scharff, CREA

OVB. Hold (unchanged) Target: Euro (unchanged) 08 May 2018

Lloyd Fonds AG. Accumulate (unchanged) Target: Euro 0.75 (unchanged)

OVB. Hold (unchanged) Target: Euro (unchanged) 26 March 2018

Sparkassen Immobilien

S IMMO. Accumulate (old: Buy) Target: Euro (old: Euro 16.00)

S IMMO. Buy (unchanged) Target: Euro (old: Euro 20.00)

OVB. Accumulate (old: Hold) Target: Euro (old: Euro 20.00) 12 May 11

CA Immo Buy (old: Accumulate)

S IMMO. Buy (old: Accumulate) Target: Euro (old: Euro 19.00)

UBM Development AG Buy (unchanged) Target: Euro (old: Euro 48.00)

Buy (unchanged) Target: Euro (unchanged)

conwert Immobilien Hold (unchanged) Target: Euro (unchanged)

UBM Development AG Buy (unchanged) Target: Euro (unchanged)

PORR Buy (unchanged) Target: Euro (old: Euro 34:00)

EYEMAXX Real Estate Buy (unchanged) Target: Euro (old: Euro 12.00)

EYEMAXX Real Estate Buy (unchanged) Target: Euro (unchanged)

MAXX Buy 10 EYEM. (unchanged) has also in its insupport. per year. from Eu- by the much. firm still. buy with. logistics. year. We.

UBM Development AG Buy Target: Euro 63.00

CA Immo Buy (unchanged) Target: Euro (old: Euro 24.00)

CA Immo Accumulate (old: Buy) Target: Euro (old: Euro 25.00)

IFM Immobilien AG. Promising 1H figures and a promising new project target price is still Target: Euro (unchanged)

Interim Report as of September 30, 2007 C-QUADRAT Investment AG

Interim Report as of June 30, 2007 C-QUADRAT Investment AG

Research Note. Fair Value REIT-AG

Vienna Insurance Group Focused on Growth in CEE and Austria. Kitzbühel Conference January 25, 2007

Annual Report C-QUADRAT Investment AG

Buy Dec 2018 TP (IDR) 4,770 Consensus Price (IDR) 4,002 TP to Consensus Price +19.2% vs. Last Price +61.1%

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

WCM. Accumulate (opening coverage) Target: Euro 3.25

Buy Dec 2017 TP (IDR) 3,250 Consensus Price (IDR) 3,469 TP to Consensus Price -6.3% vs. Last Price +18.2%

KORADO INDUSTRY: ELECTRICAL EQUIPMENT RESULTS ANALYSIS HOLD BOTTOM LINE OUTPACES EXPECTATIONS EQUITY RESEARCH BULGARIA DATE: FEBRUARY 7 TH 2018

5 November C Solarparken AG. FIRST BERLIN Equity Research

Buy Dec 2017 TP (IDR) 57,600 Consensus Price (IDR) 45,545 TP to Consensus Price +26.5% vs. Last Price +20.7%

EQUINET INVESTIGATOR

Buy Dec 2017 TP (IDR) 8,200 Consensus Price (IDR) 7,340 TP to Consensus Price +11.7% vs. Last Price +16.7%

Indygotech Minerals S.A.

adesso AG MAY 31, 2012

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

SPEEDY INDUSTRY: COURIER SERVICES RESULTS ANALYSIS GAINING MOMENTUM RECOMMENDATION: HOLD PREVIOUS RECOMMENDATION: BUY

Bupa Arabia for Cooperative Insurance Co. Insurance BUPA ARABIA 8210.SE

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research

Intershop Communications AG

Hold Dec 2018 TP (IDR) 1,850 Consensus Price (IDR) 2,193 TP to Consensus Price -15.6% vs. Last Price +4.5%

Enlargement at a bargain price

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

3M 2014 Results Presentation

Recycling assets at a premium. Vector to sell non-auckland gas assets at a premium. We view the transaction as value accretive

TOFAS. Company Update. Still offers potential value BUY. Rating. 19 February 2019

Ferratum Group reports record Q performance and full year 2017 revenue at the upper end of guidance

Annual Report C-QUADRAT Investment AG

Mobile Bank. Countries. Year-on-year profit growth. Frankfurt Prime Standard

SAFARICOM LTD EARNINGS UPDATE MAY 2016

Buy Dec 2018 TP (IDR) 10,300 Consensus Price (IDR) 8,407 TP to Consensus Price +22.5% vs. Last Price +17.0%

The Company for Cooperative Insurance Insurance TAWUNIYA AB 8010.SE

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

Summary. Investment criteria Ahlers AG Vz

Geratherm Medical AG Strong demand in Q3

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10

Bank Austria posts net profit of EUR 489 million for the first six months

18 October 2016 aventron AG. FIRST BERLIN Equity Research

BIMBO Food. Quarterly Report October 27, BIMBO Market Underperformer 2016 Price Target P$41.9

Yamama Cement Company

6 September 2016 aventron AG. FIRST BERLIN Equity Research

Hold Dec 2018 TP (IDR) 49,450 Consensus Price (IDR) 52,798 TP to Consensus Price -6.3% vs. Last Price -8.3%

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

ad pepper media International N.V.

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

Buy (Buy) Equity story yet to unfold. keplercheuvreux.com. Equity Research Espresso SANT

Neutral (Buy) MLP Price EUR10.30 (Closing price as of ) Applied disclosures can be found in the appendix

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

Forum in Frankfurt / Main

ISRA VISION Neutral

Press talk. Development Vienna Insurance Group FY Wien, 29. März 2012

Buy Dec 2017 TP (IDR) 10,200 Consensus Price (IDR) 9,393 TP to Consensus Price +8.6% vs. Last Price +17.2%

Trevi Group Italy Capital goods

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

PA Power Automation AG

> Erste Bank - Strategy and execution

WSE in H Investor Presentation. 30 August 2011

Financial Statement. as of 31 December 2013 C-QUADRAT Investment AG

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

-for professional clients only-

Q HIGHLIGHTS MEUR MEUR % MEUR MEUR 48.4 MEUR 94.8 MEUR % 1.87% +2.2% +1.9 PP +3.5% +73.8% + >100% +19.9% +81.

BUY (previous: BUY) (previous: 77.50)

Itway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009

2014 E 2015 E 2016 E 2017 E

Ahluwalia Contracts (India)

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

BUY Target Price, Rp 4,350 Upside 11,9%

Talanx Strategy Frankfurt, 23 October Torsten Leue, CEO

Longterm growth path is carried forward. Financial figures as of 30th September 2010

26 April 2017 aventron AG. FIRST BERLIN Equity Research

Transcription:

C-Quadrat Accumulate (old: Hold) Target: Euro 29.00 (old: Euro 27) 23 І October І 2012 Price (Euro) 25.00 52 weeks range 30.41 / 17.25 Key data Country Austria Industry Financial Sevices Market segment Prime Standard ISIN AT0000613005 Security ID-No. A0HG3U Symbol C8I Reuters C8I.DE Bloomberg C8I.GR Internet http://www.c-quadrat.at Reporting standard IFRS Fiscal Year 31/12 IPO 29/03/2006 Market cap (Euro m) 109.1 Shares outstanding (m) 4.36 Free float 17.7% Free float market cap. (Euro m) 19.3 CAGR pre-tax profits 11-14e 55.4% Multiples 2011 2012e 2013e 2014e P/S ratio 2.4 2.5 1.9 1.9 P/E ratio 36.4 25.2 10.7 10.5 Dividend yield 4.0% 2.8% 4.8% 4.8% EV/EBITDA 105.5 35.7 9.6 9.4 Key data per share (Euro) 2011 2012e 2013e 2014e EPS (Earnings per share) 0.69 0.99 2.33 2.39 Book value per share 6.92 7.21 8.35 9.53 Dividends per share 1.00 0.70 1.20 1.20 Financial data (Euro m) 2011 2012e 2013e 2014e Total revenues 46.0 43.4 56.1 57.1 Fee and Commission expenses -33.1-29.7-34.9-35.6 Operating profit (EBIT) 0.6 2.4 9.5 9.7 Pre-tax profit (EBT) 3.5 5.5 12.9 13.2 Net profit after minorities 3.0 4.3 10.2 10.4 Shareholders' equity 30.2 31.5 36.4 41.6 Main shareholders Talanx Asset Mgmt. 25.6% Founder Alexander Schütz** 22.5% Founder Thomas Rieß** 22.2% Svoboda/Mayer/Neubauer** 9.0% Treasury shares 3.1% ** via private foundations and directly Financial calendar 3Q 2012 5 November 2012 Analyst Internet André Hüsemann, CREA 49 (0)69 400 313-79 andre.huesemann@src-research.de www.src-research.de www.aktienmarkt-international.at New acquisitions will boost assets from Euro 2.9bn to some 4.3bn by next year Target up! Recently we met the management of C-Quadrat and talked about the latest developments within the company. In particular the acquisition of BCM as well as APM is decisive for the company and its anorganic growth. The latest good news is, that the acquisition of a 74.9% share in Absolute Portfolio Management GmbH (APM) was finally accomplished in 3Q, meaning the full consolidation started on 30 September. APM is also headquartered in Vienna, has some Euro 430m assets under management and employs 12 people. The product portfolio offers products like mutual funds, fixed income funds as well as specialty products like precious metal funds (gold and resources) and microfinance certificates. Customers are institutional clients as well as retail clients. Besides CQ, founder and managing partner Günther Kastner holds a control stock of 25.1% in APM. However, impact on CQ s 2012 numbers will be rather low, due to late consolidation this year. Meanwhile, the purchase agreement for the acquisition of a 100% share in the British asset management company BCM was also successfully signed, already on 5 September, however the final approval by the Financial Services Authority (FSA) is still missing at present day. A consolidation of the subsidiary is therefore expected starting next year at the earliest. Hence, C-Quadrat s assets under management increased already by APM s assets (Euro 430m). In addition we assume BCM s assets (Euro 800m) to boost CQ s total assets under management to some Euro 4.3bn by beginning of next year. For fiscal year 2013 we assume revenues to jump by some Euro 7m to Euro 9m, based on a gross margin on new assets under management of some 0.5% plus potential performance fees. After minorities we calculate with a profit contribution of Euro 1.5m to Euro 3.0m. But for the time being, to be on the safe side, we calculate with Euro 2m additional net profit. Considering effects of both acquisitions and the adjusted P&L figures, our DCF- valuation results in a fair value of Euro 29.51 per share, therefore we step-up our target price from 27 to 29 Euros and also lift our rating from Hold to Accumulate.

Investment Case Industry: Financial Services Management Board of C Quadrat Investment AG: Sub segment: Asset Manager Alexander Schütz StB Roland Starha Country: Austria Thomas Rieß Headquarter: Vienna Foundation 1991 Supervisory Board of C Quadrat Investment AG: Employees: 61 Dr. Markus D. Mautner Markhof (Chairman) Franz Fuchs Harry Ploemacher IR Contact Dr. Fritz Schweiger Walter Schmidt StB Roland Starha Dr. Hubert Cussigh r.starha@investmentfonds.at C Quadrat is an independent, quantitative asset manager operating across Europe. It belongs to the largest Austrian investment companies independent of banks and insurance companies. Founded in 1991, the company has its own asset management company with a bank licence since 2003 and is listed in the Prime Standard of the Frankfurt Stock Exchange since November 2006 and at the Vienna Stock Exchange since May 2008. At present fee generating assets amount to Euro 4.5bn while assets under management amount to some Euro 3.0bn, allocated in some 50 funds under management. C Quadrat has distribution agreements with distribution platforms, insurance companies and financial advisers. A total of more than 53,000 IFAs in Europe offer and distribute C Quadrats products. Countries of major importance are Germany and Austria. But in particular through unit linked life insurances C Quadrat's funds acquire assets in several CEE and SWE countries like Hungary, Czech Republic, Slovakia, Poland, Romania, Slovenia, Spain, et cetera. Retail Sales Institutional Sales IFAs (direct investments from retail clients) Insurance companies (unit linked life insurance) Platforms (direct investments from retail clients) Direct to institutional clients Source: Company Data, SRC Research 2 2 SRC Equity Research

Strengths SWOT Analysis Well established network of sales channel partners like the financial advisors AWD, OVB, Jung, DMS & Cie., insurance companies like for instance Skandia, Allianz, Deutscher Ring or distribution platforms like DAB Bank, ebase or DWS Highly scalable business model promises increasing efficiency Excellent track record in innovative fund of funds structures Business in unit-linked life-insurance policies guarantees highly stable and recurring fees, predictability of asset growth and management fees ensuring access to the lucrative insurance market Highly experienced management and sound expertise in innovative product development Well-diversified product portfolio of several different management styles (for instance Total Return-, Active Asset Allocation-, Multi Asset-, Specialized Funds) for some 50 funds under management at present Asset inflow and adoption of management mandates from major shareholder Talanx. Both companies clearly benefit from cooperation, therefore the current shareholder constellation is quite favorable Weaknesses Various awards as well as good ranking and rating (Morningstar, Lipper, S&P, Fund Award, Deutscher Fondspreis) showed the advanced competitiveness of C-Quadrat s fund products Volatile revenues due to significant share of commissions from performance fees Opportunities Asset management segment depends on capital markets, thus exposed to fluctuations New product approaches provide an attractive product line-up and match today s investor demand Scalable business model promises economies of scale Further product innovations and regional expansion allow for dynamic growth in assets under management Expansion into other European markets like CEE may accelerate growth Threats Very stable assets under management without severe backlash even under adverse conditions like seen within the financial crisis in the past years A slump in stock markets may dilute C-Quadrat s product performance, uncertainty and volatility of stock markets and economy linked to the overwhelming public debt makes it quite difficult to give a lasting projection for coming quarters 3 3 SRC Equity Research

DCF-Valuation for (Entity WACC Method) Assumptions: Equity ratio longterm 70% Beta factor 1.41 CoE Cost of Equity 7.8% Risk-free return 1.3% CoL Cost of Liability 5.1% Market risk premium 4.6% Weighted Average Cost of Capital (WACC) 7.0% Add.risk premium for C-Quadrat 0.0% Years until first pay-out 0.19 Growth in Terminal Value 1.0% ' 000 Euro 2012e 2013e 2014e 2015e 2016e Terminal Value Sales revenues 43.00 55.71 56.83 57.96 59.12 59.71 Sales growth -5.7% 29.6% 2.0% 2.0% 2.0% 1.0% EBIT margin 5.5% 17.1% 17.2% 17.4% 17.6% 14.2% EBIT 2.38 9.52 9.80 10.10 10.40 8.48 Tax on EBIT 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% Net operating profit after tax (NOPAT) 1.88 7.52 7.74 7.98 8.22 6.70 + Depreciation 0.30 0.45 0.40 0.41 0.41 0.48 +/- Changes in Working Capital -0.51 9.11 0.80 0.81 0.83-0.71 - Payouts (net) for capex -0.24-0.75-0.42-0.43-0.43-0.49 Free cash flow 1.43 16.33 8.52 8.77 9.03 5.98 Present value of free cash flows 1.41 15.08 7.35 7.07 6.81 70.49 0 PV of detailed period 37.7 PV of terminal value 70.5 Sum of free cash flows / Enterprise Value 108.2 + cash / cash equivalents 14.5 - interest bearing liabilities / long-term provisions 0 Market value of equity 128.7 PV of terminal value 65% EV breakdown Number of shares in million 4.36 Fair market value per share in Euro 29.51 PV of detailed period 35% Development of value drivers 2012e 2013e 2014e 2015e 2016e Terminal Value Sales growth -5.7% 29.6% 2.0% 2.0% 2.0% 1.0% EBIT margin 5.5% 17.1% 17.2% 17.4% 17.6% 14.2% Investment quota 0.6% 1.3% 0.7% 0.7% 0.7% 0.8% Working Capital quota 71.7% 71.7% 71.7% 71.7% 71.7% 68.9% Changes in Working Capital quota -1.2% 16.4% 1.4% 1.4% 1.4% -1.2% Sensitivity analysis (per share) Growth in Terminal Value Growth in Terminal Value EBIT Margin in Terminal Value EBIT Margin in Terminal Value 29.51 13.2% 13.7% 14.2% 14.7% 15.2% 29.51 13.2% 13.7% 14.2% 14.7% 15.2% 0.0% 26.92 27.46 28.00 28.55 29.09 6.0% 32.30 33.10 33.91 34.71 35.51 0.5% 27.53 28.11 28.70 29.28 29.87 6.5% 30.08 30.79 31.51 32.22 32.93 1.0% 28.23 28.87 29.51 30.14 30.78 7.0% 28.23 28.87 29.51 30.14 30.78 1.5% 29.07 29.77 30.46 31.16 31.86 7.5% 26.67 27.24 27.81 28.39 28.96 2.0% 30.07 30.84 31.61 32.39 33.16 8.0% 25.32 25.84 26.36 26.88 27.40 WACC 29.51 6.0% 6.5% 7.0% 7.5% 8.0% 0.0% 31.49 29.62 28.00 26.61 25.39 0.5% 32.59 30.48 28.70 27.17 25.84 1.0% 33.91 31.51 29.51 27.81 26.36 1.5% 35.51 32.74 30.46 28.57 26.96 2.0% 37.53 34.24 31.61 29.46 27.66 WACC Current share price (Euro) 25.00 Up/Downside 18.0% Source: SRC Research 4 4 SRC Equity Research

P&L Account CAGR 31/12 IFRS (Euro million) 2007 2008 2009 2010 2011 2012e 2013e 2014e '11 - '14e Fee and commission income 40,2 28,1 37,5 59,9 45,6 43,0 55,7 56,7 7,5% Other operating income 1,5 3,4 0,2 0,4 0,4 0,4 0,4 0,4 Operating income 41,7 31,5 37,7 60,3 46,0 43,4 56,1 57,1 7,5% Fee and commission expenses -21,3-15,8-21,1-36,2-33,1-29,7-34,9-35,6 Gross profit 20,4 15,7 16,6 24,1 12,8 13,7 21,3 21,6 19,0% Gross margin 49% 50% 44% 40% 28% 32% 38% 38% Personnel expenses -7,2-7,2-7,4-8,4-6,6-5,6-5,7-5,8 Other administrative & operating expenses -7,9-8,2-5,0-6,1-5,4-5,4-5,6-5,6 Total expenses -36,4-31,1-33,5-50,7-45,1-40,7-46,2-47,0 EBITDA 5,3 0,3 4,2 9,6 0,9 2,7 10,0 10,2 126,0% EBITDA-margin 13,2% 1,2% 11,1% 16,0% 1,9% 6,2% 17,9% 18,0% Depreciation including one-off items -1,2-4,1-1,7-0,2-0,3-0,3-0,4-0,5 EBIT 4,2-3,7 2,5 9,4 0,6 2,4 9,5 9,7 149,8% EBIT-margin 10,1% neg. 6,6% 15,6% 1,4% 5,5% 17,0% 17,0% Income from participations 1,4-1,4 2,1 6,4 2,5 2,7 2,9 3,0 Interest earnings 1,7 2,9 0,4 0,9 0,5 0,7 0,7 0,7 Interest costs -0,6-1,2-0,9-0,8-0,2-0,3-0,3-0,3 Pre-tax profit / EBT 6,7-3,4 4,1 15,9 3,5 5,5 12,9 13,2 55,4% EBT-margin 16,8% -12,2% 10,9% 26,5% 7,7% 12,8% 23,1% 23,2% Taxes -1,4 0,2 1,6-0,8-0,3-1,2-2,7-2,8 Tax rate 20,2% n.s. n.s. 4,8% 7,8% 21,0% 21,0% 21,0% Net profit Continued Operations 5,4-3,2 5,7 15,1 3,2 4,3 10,2 10,4 47,6% Return on sales 13,4% -11,6% 15,3% 25,2% 7,1% 10,1% 18,3% 18,4% Net profit including Discontinued Operations 5,7-12,2 5,7 15,3 3,0 4,3 10,2 10,4 Minorities -0,2 0,5-0,1 0,0 0,0 0,0 0,0 0,0 Net profit after minorities 5,5-11,6 5,6 15,3 3,0 4,3 10,2 10,4 51,4% Weighted number of shares outstanding ('000) 4.363 4.363 4.363 4.363 4.363,2 4.363,2 4.363,2 4.363,2 Earnings per share (Euro) including Discontinued Operations 1,25-2,66 1,29 3,50 0,69 0,99 2,33 2,39 51,4% Book value per share 9,95 4,76 5,45 6,92 6,92 7,21 8,35 9,53 Dividend per share 1,00 0,00 0,60 2,21 1,00 0,70 1,20 1,20 6,3% Shareholders' equity (Euro million) (without minorities) 43,4 20,8 23,8 30,2 30,2 31,5 36,4 41,6 RoE after tax 13,9% -10,1% 25,7% 56,0% 10,7% 14,1% 30,0% 26,7% Key ratios & figures 2007 2008 2009 2010 2011 2012e 2013e 2014e Growth rates in % Revenues 2,6% -30,2% 33,7% 59,7% -23,9% -5,7% 29,6% 1,8% EBITDA -0,3% -93,8% 1174,9% 129,6% -90,8% 203,5% 272,3% 2,2% EBIT -0,2% -188,8% n.s. 277,7% -93,3% 281,0% 300,3% 2,2% EBT 15,1% -150,8% n.s. 288,8% -77,9% 56,2% 134,7% 2,4% Net profit after minorities 14,1% -312,7% n.s. 172,6% -80,4% 44,4% 134,7% 2,4% Margins in % Gross 48,8% 49,8% 44,0% 39,9% 27,9% 31,5% 37,9% 37,8% EBITDA 12,7% 1,0% 11,1% 15,9% 1,9% 6,2% 17,8% 17,8% EBIT 10,1% neg. 6,6% 15,6% 1,4% 5,5% 17,0% 17,0% EBT 16,2% neg. 10,8% 26,3% 7,6% 12,6% 22,9% 23,1% Expense ratios in % Personnel costs quote 17,2% 22,7% 19,7% 13,9% 14,3% 12,9% 10,2% 10,1% Cost of material to sales 53,1% 56,3% 56,3% 60,4% 72,7% 69,1% 62,6% 62,7% Depreciation to sales 3,0% 14,5% 4,5% 0,4% 0,6% 0,7% 0,8% 0,8% Tax rate n.s. n.s. 4,8% 7,8% 21,0% 21,0% 21,0% Profitability in % Net profit to sales ratio 13,4% neg. 15,3% 25,2% 7,1% 10,1% 18,3% 18,4% Return on Equity after tax (RoE) 13,9% neg. 25,7% 56,0% 10,7% 14,1% 30,0% 26,7% Return on Assets (RoA) 9,3% neg. 13,9% 27,8% 6,8% 9,9% 22,6% 23,1% Return on Investment (RoI) 8,3% neg. 12,0% 26,4% 6,4% 9,4% 22,0% 22,5% Valuation PE-ratio 20,0 neg. 19,4 7,1 36,4 25,2 10,7 10,5 P/E-ratio (historical share price by year-end) 32,7 neg. 7,8 7,2 34,9 - - - Price/BVpS 2,51 5,25 4,59 3,61 3,61 3,47 3,00 2,62 Dividend yield in % 4,0% 0,0% 2,4% 8,8% 4,0% 2,8% 4,8% 4,8% EV/Sales 2,6 3,7 2,5 1,5 2,0 2,2 1,7 1,7 EV/EBITDA 19,9 317,5 22,3 9,4 105,5 35,7 9,6 9,4 Data per share Share price by year end 41,00 8,34 10,00 25,26 24,00 - - - Number of shares in m 4,4 4,4 4,4 4,4 4,4 4,4 4,4 4,4 EpS 1,25-2,66 1,29 3,50 0,69 0,99 2,33 2,39 DpS 1,00 0,00 0,60 2,21 1,00 0,70 1,20 1,20 BVpS 9,95 4,76 5,45 6,92 6,92 7,21 8,35 9,53 5 5 SRC Equity Research

SRC Research The Specialist for Financial and Real Estate Stocks SRC-Scharff Research und Consulting GmbH Klingerstrasse 23 D-60313 Frankfurt Germany Fon: +49 (0)69 / 400 313-79 E-Mail: andre.huesemann@src-research.de Internet: www.src-research.de Rating chronicle Date Rating former share price former target C-Quadrat 14 Aug 2012 Hold 27.80 27.00 C-Quadrat 10 May 2012 Accumulate 26.30 27.00 C-Quadrat 27 Mar 2012 Buy 23.80 26.00 C-Quadrat 15 Feb 2012 Buy 23.80 26.00 C-Quadrat 08 Nov 2011 Buy 22.08 27.00 C-Quadrat 17 Aug 2011 Buy 25.00 30.00 Please note: The C-Quadrat share price mentioned in this report is from closing of 22 October 2012. C-Quadrat mandated SRC Research for mentoring the C- Quadrat share. Disclaimer 2012: This equity research report is published by: SRC-Scharff Research und Consulting GmbH (short name: SRC Research), Klingerstr. 23, D-60313 Frankfurt, Germany. All rights reserved. Although we feel sure that all information in this SRC report stem from carefully selected sources with a high credibility, we cannot give any guarantee for accuracy, trueness and completeness. All opinions quoted in this report give the current judgement of the author that not necessarily is the same opinion as SRC-Scharff Research und Consulting GmbH or another staff member. All in this report made opinions and judgements might be changed without a pre-announcement. Within the scope of German regulative framework author and SRC- Scharff Research und Consulting GmbH do not assume any liability for using this document or its content. This report is just for information purposes and not a request or an invitation or a recommendation to buy or sell any stock that is mentioned here. Private clients should search for personal advice at their bank or investment house and should keep in mind that prices and dividends of equities might rise and fall and that nobody can give a guarantee of the future development of equities. The author of this report and the SRC-Scharff Research und Consulting GmbH commit themselfes on a unsolicited basis to have no long- or short-positions in equities or derivatives related to equities mentioned in this report. Reproduction, distribution and publishing of this report and its content as a whole or in parts is only allowed with an approval of SRC management board in written form. With acceptance of this document you agree with all regulations mentioned here and all general terms and conditions you will find at anytime at our website www.src-research.de. 6 6 SRC Equity Research